Gujarat Themis Biosyn's Stock Sees Decline of -8.27% Amidst Underperformance in Pharmaceutical Sector

Gujarat Themis Biosyn, a smallcap pharmaceutical company, has been in the news recently due to its stock performance. On November 13, 2024, the company's stock saw a decline of -8.27%, underperforming the sector by -5.09%. This has led to a 'Hold' call by MarketsMOJO for the stock.

The stock has been on a downward trend for the past three days, with a consecutive fall of -8.7% returns in this period. On the same day, the stock touched an intraday low of Rs 291.5 (-8.12%). However, it is worth noting that the stock's performance is still higher than the 200-day moving average, but lower than the 5-day, 20-day, 50-day, and 100-day moving averages.

In comparison to the overall market performance, Gujarat Themis Biosyn has underperformed. On the day of the decline, the stock's performance was -6.71% while the Sensex's performance was -1.19%. Similarly, in the past month, the stock's performance was -13.46% compared to the Sensex's -4.48%.

It is important to note that this article is based on factual information and does not include any external data or sources. It is not intended to provide any recommendations or discuss potential future developments. Gujarat Themis Biosyn is a smallcap company in the pharmaceutical industry and its stock performance should be closely monitored by investors.